Td Waterhouse Canada Inc. Merus N.V. Transaction History

Td Waterhouse Canada Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$20.13 - $27.29 $1,932 - $2,619	-96 Closed	0 $0
Q2 2022 Nov 13, 2023	SELL	$13.98 - $29.25 $283,458 - $593,073	-20,276 Reduced 99.53%	96 $2.14 Million
Q1 2022 Nov 13, 2023	BUY	$23.58 - $30.91 $46,759 - $61,294	1,983 Added 10.78%	20,372 $555 Million
Q4 2021 Nov 13, 2023	BUY	$20.0 - $32.29 $367,780 - $593,780	18,389 New	18,389 $544 Million

200

61.9M

243K

300K

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $2.28B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

Stay updated on Td Waterhouse Canada Inc. with notifications on news.